Vascular Shutdown by Photodynamic Therapy Using Talaporfin Sodium

Photodynamic therapy (PDT) is an attractive cancer treatment modality. Talaporfin sodium, a second-generation photosensitizer, results in lower systemic toxicity and relatively better selective tumor destruction than first-generation photosensitizers. However, the mechanism through which PDT induces...

Full description

Bibliographic Details
Main Authors: Taketo Suzuki, Mamoru Tanaka, Makiko Sasaki, Hiroshi Ichikawa, Hirotada Nishie, Hiromi Kataoka
Format: Article
Language:English
Published: MDPI AG 2020-08-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/12/9/2369
_version_ 1797556441214615552
author Taketo Suzuki
Mamoru Tanaka
Makiko Sasaki
Hiroshi Ichikawa
Hirotada Nishie
Hiromi Kataoka
author_facet Taketo Suzuki
Mamoru Tanaka
Makiko Sasaki
Hiroshi Ichikawa
Hirotada Nishie
Hiromi Kataoka
author_sort Taketo Suzuki
collection DOAJ
description Photodynamic therapy (PDT) is an attractive cancer treatment modality. Talaporfin sodium, a second-generation photosensitizer, results in lower systemic toxicity and relatively better selective tumor destruction than first-generation photosensitizers. However, the mechanism through which PDT induces vascular shutdown is unclear. In this study, the in vitro effects of talaporfin sodium-based PDT on human umbilical vein endothelial cells (HUVECs) were determined through cell viability and endothelial tube formation assays, and evaluation of the tubulin and F-actin dynamics and myosin light chain (MLC) phosphorylation. Additionally, the effects on tumor blood flow and tumor vessel destruction were assessed in vivo. In the HUVECs, talaporfin sodium-based PDT induced endothelial tube destruction and microtubule depolymerization, triggering the formation of F-actin stress fibers and a significant increase in MLC phosphorylation. However, pretreatment with the Rho-associated protein kinase (ROCK) inhibitor, Y27632, completely prevented PDT-induced stress fiber formation and MLC phosphorylation. The in vivo analysis and pathological examination revealed that the PDT had significantly decreased the tumor blood flow and the active area of the tumor vessel. We concluded that talaporfin sodium-based PDT induces the shutdown of existing tumor vessels via the RhoA/ROCK pathway by activating the Rho-GTP pathway and decreasing the tumor blood flow.
first_indexed 2024-03-10T17:02:52Z
format Article
id doaj.art-76a20e51b769452490b5c00f33b3fac3
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-10T17:02:52Z
publishDate 2020-08-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-76a20e51b769452490b5c00f33b3fac32023-11-20T10:54:13ZengMDPI AGCancers2072-66942020-08-01129236910.3390/cancers12092369Vascular Shutdown by Photodynamic Therapy Using Talaporfin SodiumTaketo Suzuki0Mamoru Tanaka1Makiko Sasaki2Hiroshi Ichikawa3Hirotada Nishie4Hiromi Kataoka5Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical, Nagoya 467-8601, JapanDepartment of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical, Nagoya 467-8601, JapanDepartment of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical, Nagoya 467-8601, JapanDepartment of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical, Nagoya 467-8601, JapanDepartment of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical, Nagoya 467-8601, JapanDepartment of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical, Nagoya 467-8601, JapanPhotodynamic therapy (PDT) is an attractive cancer treatment modality. Talaporfin sodium, a second-generation photosensitizer, results in lower systemic toxicity and relatively better selective tumor destruction than first-generation photosensitizers. However, the mechanism through which PDT induces vascular shutdown is unclear. In this study, the in vitro effects of talaporfin sodium-based PDT on human umbilical vein endothelial cells (HUVECs) were determined through cell viability and endothelial tube formation assays, and evaluation of the tubulin and F-actin dynamics and myosin light chain (MLC) phosphorylation. Additionally, the effects on tumor blood flow and tumor vessel destruction were assessed in vivo. In the HUVECs, talaporfin sodium-based PDT induced endothelial tube destruction and microtubule depolymerization, triggering the formation of F-actin stress fibers and a significant increase in MLC phosphorylation. However, pretreatment with the Rho-associated protein kinase (ROCK) inhibitor, Y27632, completely prevented PDT-induced stress fiber formation and MLC phosphorylation. The in vivo analysis and pathological examination revealed that the PDT had significantly decreased the tumor blood flow and the active area of the tumor vessel. We concluded that talaporfin sodium-based PDT induces the shutdown of existing tumor vessels via the RhoA/ROCK pathway by activating the Rho-GTP pathway and decreasing the tumor blood flow.https://www.mdpi.com/2072-6694/12/9/2369photodynamic therapyRho-GTP pathwaytalaporfin sodiumvascular shutdown effect
spellingShingle Taketo Suzuki
Mamoru Tanaka
Makiko Sasaki
Hiroshi Ichikawa
Hirotada Nishie
Hiromi Kataoka
Vascular Shutdown by Photodynamic Therapy Using Talaporfin Sodium
Cancers
photodynamic therapy
Rho-GTP pathway
talaporfin sodium
vascular shutdown effect
title Vascular Shutdown by Photodynamic Therapy Using Talaporfin Sodium
title_full Vascular Shutdown by Photodynamic Therapy Using Talaporfin Sodium
title_fullStr Vascular Shutdown by Photodynamic Therapy Using Talaporfin Sodium
title_full_unstemmed Vascular Shutdown by Photodynamic Therapy Using Talaporfin Sodium
title_short Vascular Shutdown by Photodynamic Therapy Using Talaporfin Sodium
title_sort vascular shutdown by photodynamic therapy using talaporfin sodium
topic photodynamic therapy
Rho-GTP pathway
talaporfin sodium
vascular shutdown effect
url https://www.mdpi.com/2072-6694/12/9/2369
work_keys_str_mv AT taketosuzuki vascularshutdownbyphotodynamictherapyusingtalaporfinsodium
AT mamorutanaka vascularshutdownbyphotodynamictherapyusingtalaporfinsodium
AT makikosasaki vascularshutdownbyphotodynamictherapyusingtalaporfinsodium
AT hiroshiichikawa vascularshutdownbyphotodynamictherapyusingtalaporfinsodium
AT hirotadanishie vascularshutdownbyphotodynamictherapyusingtalaporfinsodium
AT hiromikataoka vascularshutdownbyphotodynamictherapyusingtalaporfinsodium